Sun Pharmaceutical vs Cipla: which is the better buy right now?
As of 30 Sep 2026, Firefly's strategy has Sun Pharmaceutical on wait and Cipla on wait. Since October 2024, simulated on historical prices — Sun Pharmaceutical: 0 of 1 Buy signals closed above the entry price (average −6.6%). This compares one rule set's record, not a recommendation of one over the other.
SUNPHARMA NSE
Sun Pharmaceutical · Pharma
Wait
Firefly Breakout Weekly · no open signal
₹1,746.40 last in log · 14 Oct 2026
Full SUNPHARMA page →CIPLA NSE
Cipla · NSE F&O stocks
Wait
Firefly Breakout Weekly · no open signal
₹1,314.60 last in log · 14 Oct 2026
Full CIPLA page →Side by side
Firefly Breakout Weekly · as of 30 Sep 20261
Buy signals since Oct 2024
0
0%
Closed above entry
—
−6.6%
Avg outcome per signal
—
8 wk
Typical hold
4 wk
Questions about SUNPHARMA vs CIPLA
Should I buy Sun Pharmaceutical or Cipla?
As of 30 Sep 2026, Firefly's strategy has Sun Pharmaceutical on wait and Cipla on wait. That describes one rule set's signal, not a recommendation.
Which is safer, SUNPHARMA or CIPLA?
Rule-based strategies don't measure safety. What this page can show is each one's record since October 2024, simulated on historical prices: 0 of 1 Buy signals on SUNPHARMA closed above the entry price, against none on CIPLA. Past signals do not predict future prices.
Can I hold both SUNPHARMA and CIPLA?
They sit in different sectors (Pharma and NSE F&O stocks), so the macro rules read them differently and they may diversify each other. Portfolio construction is outside what these pages cover.
Fintrens compares how Firefly's rule-based strategies read two stocks. Educational information, not investment advice. Read how Firefly's strategies work →